PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

Angiosarcoma of the liver is a rare, aggressive form of cancer that develops in the cells involved in immune system response. It accounts for about 0.1–2% of all liver cancers, but is the third most ...

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

How spreading tumour cells gain the ability to grow in organs away from where they originated is not fully understood. The discovery that normal liver cells help invading tumour cells to thrive in ...

Cancer of the liver, seen in a radial cross-section abdominal scan. (Photo by: BSIP/Universal Images Group via Getty Images) The number of new liver cancer cases will nearly double in the next 25 ...

According to the Centers for Disease Control and Prevention (CDC), approximately 25,000 men and 11,000 women are diagnosed with liver cancer each year. Early detection and treatment are key to ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Most people who develop this cancer have chronic liver disease. Treatments typically include surgery, chemotherapy, ...

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...